Continuous Renal Replacement Therapy Market
anticipated to reach USD 1.4 billion by 2025
The global Continuous Renal Replacement Therapy (CRRT) market size was valued at around USD 745.4
million in 2016 and is anticipated to reach USD 1.4 billion by 2025, with a CAGR of 7.4%. Acute renal failure
is a common complication in the intensive care unit (ICU). Over the last few years, there have been noteworthy
technological developments in the delivery of renal replacement therapy, principally as it refers to the critically
ill patient population.
Continuous Renal Replacement Therapy (CRRT) is a dialysis modality utilized to treat critically ill,
hospitalized patients in the intensive care unit (ICU) who develop acute kidney injury (AKI). Dissimilar to that
of chronic kidney disease, which arises gradually over the period of time, AKI often takes place in hospitalized
patients treated in an intensive care environment, and it classically occurs over a few hours to a few days.
Renal replacement therapy is one treatment modality that strives for the replacement of the excretory function
of the kidney. Renal replacement always utilizes a semi-permeable membrane to accomplish blood purification.
It can be alternating or continuous, and can involve some of the major transport mechanisms such as the
convection, adsorption, diffusion, and ultra-filtration. The effort of this is continuous renal replacement
Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry-
Continuous renal replacement therapy (CRRT) is a widespread optimal for the cure of ICU patients with AKI,
particularly for hemodynamically unbalanced circumstances. CRRT consists of solute removal from blood by
hemofiltration or haemodialysis or a blend of both. CRRT is carried out for about 24 hours in an ICU, making it
relatively different from traditional renal replacement therapies that consist of intermittent haem